PedAM
Pediatric Disease Annotations & Medicines
| Disease | mental depression |
| Phenotype | C0019158|hepatitis |
| Sentences | 35 |
| PubMedID- 21423320 | Not only is the prevalence of depression in patients with hepatitis c higher than the general population, antiviral therapy increases the likelihood of a variety of neuropsychiatric complications, including worsening depression, anxiety, and suicidal ideation [28]. |
| PubMedID- 26338025 | Patients treated with ifn as a therapy against hepatitis and certain forms of cancer develop depression and suicidality at a significantly increased rate [5, 54]. |
| PubMedID- 23108508 | The role of attachment style and depression in patients with hepatitis c. |
| PubMedID- 24934987 | depression was not associated with hepatitis c (hcv-infected 29%, non-infected 35%; p = 0.25). |
| PubMedID- 23942342 | A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis c infection. |
| PubMedID- 25868672 | We prospectively evaluate depressive symptoms and risk factors for major depression in patients with hepatitis c virus treated with antiviral combined therapy. |
| PubMedID- 24918850 | Interferon-induced depression in patients with hepatitis c: an epidemiologic study. |
| PubMedID- 21654873 | We suggest that interactions between psychobehavioral, genetic, and biological risk factors are of particular importance in the occurrence of depression in patients with hepatitis c taking interferon-α. |
| PubMedID- 25670957 | Bupropion for interferon-alpha-induced depression in patients with hepatitis c viral infection: an open-label study. |
| PubMedID- 23648373 | Specific serotonin reuptake inhibitors prevent interferon-alpha-induced depression in patients with hepatitis c: a meta-analysis. |
| PubMedID- 21691274 | Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-alpha-induced depression in patients with chronic hepatitis c. |
| PubMedID- 25359924 | Conclusions: pre-treatment screening for subthreshold depressive and cognitive symptoms will help to identify those at risk for ifn-alpha-associated depression among patients with chronic hepatitis c. |
| PubMedID- 24204676 | Can antidepressants prevent pegylated interferon-alpha/ribavirin-associated depression in patients with chronic hepatitis c: meta-analysis of randomized, double-blind, placebo-controlled trials. |
| PubMedID- 22075738 | Objective: to prospectively evaluate depressive symptoms and risk factors for depression in patients with chronic hepatitis c (chc) treated with pegylated interferon alpha therapy combined with oral ribavirin (peg-ifn-alpha+rbv) and to analyze self-rating scale for depression in comparison to observer-based scale in the given population. |
| PubMedID- 21762832 | Screening for depression in patients with hepatitis c using the beck depression inventory-ii: do somatic symptoms compromise validity. |
| PubMedID- 24955454 | Conclusions: a history of depression is common with hepatitis c but does not affect initiation of antiviral treatment, despite substantially increased risk of psychiatric side-effects. |
| PubMedID- 25116763 | Incidence of depression in patients with chronic hepatitis c receiving combination therapy of pegylated interferon-alpha and ribavirin. |
| PubMedID- 24372654 | Objective: to conduct a systematic review and meta-analysis evaluating the efficacy and safety of antidepressant medications for the prevention of interferon-alpha (inf-alpha)-associated depression in patients with chronic hepatitis c virus (hcv). |
| PubMedID- 25663386 | There was a significantly higher rate of depression in patients with hepatitis than in healthy participants (p = 0.003). |
| PubMedID- 20587769 | Novel treatment strategies for depression in patients with hepatitis c. |
| PubMedID- 24778869 | A preliminary study on the relationship between platelet serotonin transporter functionality, depression, and fatigue in patients with untreated chronic hepatitis c. |
| PubMedID- 26446640 | The risk of external-cause mortality, especially suicide, may be associated with antiviral treatment, as interferon-α treatment has been shown to be associated with increased risk of suicide or major depression in patients with hepatitis,36 and most trials report a 10% to 40% incidence of major depression during antiviral therapy.37 hepatitis b virus infection is highly prevalent in asia and africa, and nationwide vaccination strategies have been adopted to eliminate hepatitis b virus infection in korea. |
| PubMedID- 24742598 | depression and neuroticism in patients with chronic hepatitis c: correlation with peripheral blood mononuclear cells activation. |
| PubMedID- 23139898 | Gene expression profiles associated with depression in patients with chronic hepatitis c (ch-c). |
| PubMedID- 22326842 | depression and anxiety in patients with hepatitis c virus (hcv) infection influence their health-related quality of life and their adherence to antiviral treatment. |
| PubMedID- 24834219 | depression in patients with chronic hepatitis b: an experience on individual solution- focused therapy. |
| PubMedID- 24608155 | Interferon-alpha induced depression in a patient with hepatitis c. |
| PubMedID- 24608038 | Asymmetric dimethylarginine responses during interferon-alpha-induced depression in patients with chronic hepatitis c infection. |
| PubMedID- 22070000 | Objective: the aim of the study was to identify the presence of depression in patients with chronic hepatitis c, predicting factors for its expression, and the impact of depression on the quality of life in these patients. |
| PubMedID- 24012293 | Conclusion: antidepressant pretreatment with selective serotonin reuptake inhibitors lowers the incidence and severity of ifn-associated depression in patients with chronic hepatitis c infection or malignant melanoma. |
| PubMedID- 24644496 | Conclusion: there is a high prevalence of depression among patients with hepatitis b and hepatitis c infection, especially patients on interferon therapy. |
| PubMedID- 24839091 | Serotonin-norepinephrine reuptake inhibitor desvenlafaxine for the treatment of interferon alfa-associated depression in patients with hepatitis c. |
| PubMedID- 21615916 | For instance, ido activity (measured indirectly by the kyn/trp ratio) and an increased neurotoxic potential predict the occurrence of depression in patients with hepatitis c being treated with ifn-α based immunotherapy [34,35]. |
| PubMedID- 20569656 | The prevalence of depression is increased in patients with chronic hepatitis c virus (hcv) infection. |
| PubMedID- 23058145 | Severity of depression in hepatitis b and hepatitis c patients. |
Page: 1